You are here

Clinical Trials: Central Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, February 16, 2015 - 12:00
Condition:   Cerebral Infarction
Interventions:   Biological: Cordstem-ST;   Biological: Placebo
Sponsor:   CHABiotech CO., Ltd
Recruiting - verified February 2015
Posted: Thursday, February 5, 2015 - 12:00
Condition:   Stroke
Interventions:   Device: Telerehabilitation Therapy;   Behavioral: In-Clinic Therapy
Sponsor:   University of California, Irvine
Recruiting - verified June 2016
Posted: Tuesday, February 3, 2015 - 12:00
Conditions:   Mild Cognitive Impairment;   Alzheimer's Disease;   Dementia
Intervention:   Drug: Flutemetamol (Vizamyl)
Sponsor:   University of Zurich
Recruiting
Posted: Monday, November 24, 2014 - 12:00
Conditions:   Cervical Spinal Cord Injury;   Spine Injury;   Spinal Cord Trauma
Intervention:   Biological: AST-OPC1
Sponsor:   Asterias Biotherapeutics, Inc.
Recruiting - verified May 2016
Posted: Thursday, November 6, 2014 - 12:00
Condition:   Urea Cycle Disorders
Intervention:   Biological: HepaStem
Sponsor:   Promethera Biosciences
Recruiting - verified June 2015
Posted: Friday, October 31, 2014 - 12:00
Conditions:   Hypoxic Ischemic Encephalopathy;   Umbilical Cord Milking
Intervention:   Procedure: Umbilical Cord Milking
Sponsors:   Thomas Jefferson University;   Lata Mangeshkar Hospital, NKP Salve Institute of Medical Sciences, Nagpur, India
Recruiting - verified April 2016
Posted: Friday, October 24, 2014 - 12:00
Condition:   ALS (Amyotrophic Lateral Sclerosis)
Interventions:   Biological: MNC (Mononuclear cells);   Other: Saline
Sponsors:   Red de Terapia Celular;   Spanish National Health System;   Hospital Universitario Virgen de la Arrixaca;   Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia;   Public Health Service, Murcia;   Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Recruiting - verified September 2015
Posted: Thursday, October 9, 2014 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Other: Intravenous administration of placebo;   Drug: Intravenous administration of 1 million of MSC;   Drug: Intravenous administration of 2 million of MSC;   Drug: Intravenous administration of 4 million of MSC
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas
Recruiting - verified December 2015
Posted: Thursday, October 2, 2014 - 12:00
Condition:   Mesenchymal Stromal Cells
Intervention:   Drug: pneumostem
Sponsor:   Samsung Medical Center
Recruiting - verified April 2016
Posted: Wednesday, October 1, 2014 - 12:00
Conditions:   Neonatal Encephalopathy;   Hypoxic-ischemic Encephalopathy
Intervention:   Other: Autologous umbilical cord blood cells
Sponsors:   Neonatal Encephalopathy Consortium, Japan;   Osaka City University;   Yodogawa Christian Hospital;   Kurashiki Central Hospital;   Nagoya University;   Osaka City General Hospital;   Saitama Medical University;   National Cerebral and Cardiovascular Center;   National Center for Child Health and Development, Japan;   Tokyo University;   Tokyo Women's Medical University
Recruiting - verified October 2014

Pages